A population-based case -control study of lymphomas in England collected height and weight details from 699 non-Hodgkin's lymphoma (NHL) cases and 914 controls. Obesity, defined as a body mass index (BMI) over 30 kg m À2 at five years before diagnosis,, was associated with an increased risk of NHL (OR ¼ 1.5, 95% CI 1.1 -2.1). The excess was most pronounced for diffuse large B-cell lymphoma (OR ¼ 1.9, 95% CI 1.3 -2.8). Genetic variants in the leptin (LEP 19G4A, LEP À2548G4A) and leptin receptor genes (LEPR 223Q4R), previously shown to modulate NHL risk, as well as a polymorphism in the energy regulatory gene adiponectin (APM1 276G4T), were investigated. Findings varied with leptin genotype, the risks being decreased with LEP 19AA (OR ¼ 0.7, 95% CI 0.5 -1.0) and increased with LEP À2548GA (OR ¼ 1.3, 95% CI 1.0 -1.7) and À2548AA (OR ¼ 1.4, 95% CI 1.0 -1.9), particularly for follicular lymphoma. These genetic findings, which were independent of BMI, were stronger for men than women.